Literature DB >> 24787547

Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model.

Kathryn M Gill1, Anthony A Grace1.   

Abstract

Alteration in normal hippocampal (HPC) function attributed to reduced parvalbumin (PV) expression has been consistently reported in schizophrenia patients and in animal models of schizophrenia. However, it is unclear whether there is an overall loss of interneurons as opposed to a reduction in activity-dependent PV content. Co-expression of PV and the constitutively expressed substance P (SP)-receptor protein has been utilized in other models to ascertain the degree of cell survival, as opposed to reduction in activity-dependent PV content, in the HPC. The present study measured the co-expression of PV and SP-receptors in the dentate and dorsal and ventral CA3 subregions of the HPC in the methylazoymethanol acetate (MAM) rat neurodevelopmental model of schizophrenia. In addition, these changes were compared at the post-natal day 27 (PND27) and post-natal day 240 (PND > 240) time points. Brains from PND27 and PND > 240 MAM (n = 8) and saline (SAL, n = 8) treated offspring were immunohistochemically processed for the co-expression of PV and SP-receptors. The dorsal dentate, dorsal CA3 and ventral CA3 subregions of PND27 and PND > 240 MAM rats demonstrated significant reductions in PV but not SP-receptor expression, signifying a loss of PV-content. In contrast, in the ventral dentate the co-expression of PV and SP-receptors was significantly reduced only in PND > 240 MAM animals, suggesting a reduction in cell number. While MAM-induced reduction of PV content occurs in CA3 of dorsal and ventral HPC, the most substantial loss of interneuron number is localized to the ventral dentate of PND > 240 animals. The disparate loss of PV in HPC subregions likely impacts intra-HPC network activity in MAM rats.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24787547      PMCID: PMC4161636          DOI: 10.1017/S146114571400056X

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  75 in total

Review 1.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

2.  Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia.

Authors:  Eric C Zimmerman; Mark Bellaire; Samuel G Ewing; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

3.  Parvalbumin-containing chandelier and basket cell boutons have distinctive modes of maturation in monkey prefrontal cortex.

Authors:  Kenneth N Fish; Gil D Hoftman; Wasiq Sheikh; Michael Kitchens; David A Lewis
Journal:  J Neurosci       Date:  2013-05-08       Impact factor: 6.167

4.  Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.

Authors:  Yijuan Du; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

5.  Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance.

Authors:  Gil D Hoftman; David W Volk; H Holly Bazmi; Siyu Li; Allan R Sampson; David A Lewis
Journal:  Schizophr Bull       Date:  2013-12-22       Impact factor: 9.306

6.  Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.

Authors:  Tsutomu Sakai; Akihiko Oshima; Yusuke Nozaki; Itsuro Ida; Chie Haga; Haruhiko Akiyama; Yoichi Nakazato; Masahiko Mikuni
Journal:  Neuropathology       Date:  2007-12-05       Impact factor: 1.906

7.  Differential regulation of parvalbumin and calretinin interneurons in the prefrontal cortex during adolescence.

Authors:  Adriana Caballero; Eden Flores-Barrera; Daryn K Cass; Kuei Y Tseng
Journal:  Brain Struct Funct       Date:  2013-02-12       Impact factor: 3.270

8.  Region-specific upregulation of parvalbumin-, but not calretinin-positive cells in the ventral hippocampus during adolescence.

Authors:  Adriana Caballero; Kimberly C Diah; Kuei Y Tseng
Journal:  Hippocampus       Date:  2013-09-02       Impact factor: 3.899

9.  Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  J Neurosci       Date:  2007-10-17       Impact factor: 6.167

10.  Induced gamma activity and event-related coherence in schizophrenia.

Authors:  P Bucci; A Mucci; E Merlotti; U Volpe; S Galderisi
Journal:  Clin EEG Neurosci       Date:  2007-04       Impact factor: 1.843

View more
  28 in total

Review 1.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

Review 2.  Stress during critical periods of development and risk for schizophrenia.

Authors:  Felipe V Gomes; Xiyu Zhu; Anthony A Grace
Journal:  Schizophr Res       Date:  2019-01-30       Impact factor: 4.939

Review 3.  Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.

Authors:  Felipe V Gomes; Millie Rincón-Cortés; Anthony A Grace
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

4.  Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.

Authors:  Kathryn M Gill; Sarah A Miller; Anthony A Grace
Journal:  Schizophr Res       Date:  2017-09-18       Impact factor: 4.939

Review 5.  Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.

Authors:  Susan F Sonnenschein; Anthony A Grace
Journal:  Neuropharmacology       Date:  2019-05-08       Impact factor: 5.250

Review 6.  Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?

Authors:  Helen E Scharfman; Andres M Kanner; Alon Friedman; Ingmar Blümcke; Candice E Crocker; Fernando Cendes; Ramon Diaz-Arrastia; Hans Förstl; André A Fenton; Anthony A Grace; Jorge Palop; Jason Morrison; Astrid Nehlig; Asuri Prasad; Karen S Wilcox; Nathalie Jette; Bernd Pohlmann-Eden
Journal:  Epilepsy Behav       Date:  2017-10-31       Impact factor: 2.937

Review 7.  Cellular and circuit models of increased resting-state network gamma activity in schizophrenia.

Authors:  R S White; S J Siegel
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

8.  Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.

Authors:  Gen Kaneko; Basavaraju G Sanganahalli; Stephanie M Groman; Helen Wang; Daniel Coman; Jyotsna Rao; Peter Herman; Lihong Jiang; Katherine Rich; Robin A de Graaf; Jane R Taylor; Fahmeed Hyder
Journal:  Biol Psychiatry       Date:  2016-05-30       Impact factor: 13.382

9.  Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice.

Authors:  Daniel Scott; Carol A Tamminga
Journal:  Behav Brain Res       Date:  2017-11-15       Impact factor: 3.332

Review 10.  The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.

Authors:  Anthony A Grace; Felipe V Gomes
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.